1-3 of 3
Roger Sidhu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preliminary Results from a Phase 1b/2 Open-Label, Multicenter, Dose Optimization Clinical Study of the Safety, Tolerability, and Pharmacokinetic (PK) and Pharmacodynamic (PD) Profiles of Cfi-400945 As a Single Agent or in Combination with Azacitidine in Patients (Pts) with Acute Myeloid Leukemia, Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (TWT-202)

Brian A. Jonas, Karen Yee, Alice Mims, Paul B. Koller, Joseph Brandwein, Gail J. Roboz, Glenn Michelson, Linh Nguyen, Mark R Bray, Emily Roberts-Thomson, Roger Sidhu, Gautam Borthakur
Journal: Blood
Blood (2023) 142 (Supplement 1): 4294.
https://doi.org/10.1182/blood-2023-182027
Published: 2023
Journal Articles

Developing a Multidimensional Prognostic Test for Follicular Lymphoma.

Cheryl J. Foster, BSc, Tara Baetz, MD, Roland Somogyi, PhD, Larry D. Greller, PhD, Roger Sidhu, MD, Patricia Farmer, MD, Harriet E. Feilotter, PhD, David P. LeBrun, MD
Journal: Blood
Blood (2007) 110 (11): 2610.
https://doi.org/10.1182/blood.V110.11.2610.2610
Published: 2007
Journal Articles

Pre-Clinical Validation of Polo-Like Kinase 1 as a Therapeutic Target in Multiple Myeloma with the Selective Inhibitor BI2536.

Roger Sidhu, MD, Tara Steffler, Gail Hipperson, Michelle Jung, Joyce Fung, Linda M. Pilarski, PhD, Andrew R. Belch, MD, Tony Reiman, MD, MSc
Journal: Blood
Blood (2007) 110 (11): 2514.
https://doi.org/10.1182/blood.V110.11.2514.2514
Published: 2007